154.73
price up icon0.08%   0.12
 
loading
Schlusskurs vom Vortag:
$154.61
Offen:
$155.6
24-Stunden-Volumen:
2.64M
Relative Volume:
1.15
Marktkapitalisierung:
$27.64B
Einnahmen:
$15.50B
Nettoeinkommen (Verlust:
$1.33B
KGV:
21.08
EPS:
7.34
Netto-Cashflow:
$2.16B
1W Leistung:
-1.38%
1M Leistung:
+6.75%
6M Leistung:
-21.56%
1J Leistung:
-27.76%
1-Tages-Spanne:
Value
$153.82
$156.91
1-Wochen-Bereich:
Value
$153.22
$159.85
52-Wochen-Spanne:
Value
$134.65
$252.88

Iqvia Holdings Inc Stock (IQV) Company Profile

Name
Firmenname
Iqvia Holdings Inc
Name
Telefon
919-998-2000
Name
Adresse
2400 ELLIS ROAD, DURHAM, NC
Name
Mitarbeiter
89,000
Name
Twitter
@IQVIA_global
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
IQV's Discussions on Twitter

Vergleichen Sie IQV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
154.73 27.64B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
397.88 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
196.39 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
523.92 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
115.56 34.24B 6.63B 1.17B 1.19B 4.05

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-25 Herabstufung HSBC Securities Buy → Hold
2025-04-10 Herabstufung Barclays Overweight → Equal Weight
2025-02-03 Herabstufung BTIG Research Buy → Neutral
2024-12-20 Eingeleitet Stephens Overweight
2024-10-14 Eingeleitet Redburn Atlantic Buy
2024-09-04 Eingeleitet RBC Capital Mkts Outperform
2024-07-24 Herabstufung Jefferies Buy → Hold
2024-06-06 Eingeleitet Goldman Buy
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-02-15 Herabstufung Guggenheim Buy → Neutral
2024-02-13 Eingeleitet BTIG Research Buy
2023-11-02 Herabstufung Robert W. Baird Outperform → Neutral
2023-09-06 Eingeleitet HSBC Securities Buy
2023-03-17 Eingeleitet Truist Buy
2022-12-06 Eingeleitet Cowen Outperform
2022-11-17 Herabstufung Citigroup Buy → Neutral
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-07-15 Eingeleitet SVB Leerink Outperform
2022-05-24 Eingeleitet Guggenheim Buy
2022-04-29 Hochstufung Piper Sandler Neutral → Overweight
2022-04-25 Herabstufung Wells Fargo Overweight → Equal Weight
2021-08-05 Fortgesetzt Credit Suisse Outperform
2021-04-16 Hochstufung Stephens Equal-Weight → Overweight
2021-03-08 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2021-03-03 Eingeleitet Barclays Overweight
2020-07-07 Eingeleitet Stephens Equal-Weight
2020-03-02 Eingeleitet Deutsche Bank Buy
2020-01-08 Eingeleitet Wells Fargo Overweight
2020-01-07 Eingeleitet Citigroup Buy
2019-12-13 Hochstufung CFRA Sell → Hold
2019-11-14 Hochstufung Wolfe Research Peer Perform → Outperform
2019-06-21 Hochstufung Mizuho Neutral → Buy
2019-05-28 Eingeleitet SVB Leerink Outperform
2019-01-18 Hochstufung Jefferies Hold → Buy
2018-10-09 Eingeleitet UBS Buy
2018-10-02 Bestätigt Robert W. Baird Outperform
2018-07-25 Hochstufung BofA/Merrill Neutral → Buy
2018-07-25 Bestätigt Stifel Buy
2018-07-03 Hochstufung Raymond James Outperform → Strong Buy
2018-04-13 Hochstufung Goldman Neutral → Buy
2018-03-07 Hochstufung SunTrust Hold → Buy
2018-01-19 Eingeleitet Evercore ISI Outperform
Alle ansehen

Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten

pulisher
Jun 17, 2025

Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Yahoo Finance

Jun 17, 2025
pulisher
Jun 16, 2025

IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ - Business Wire

Jun 16, 2025
pulisher
Jun 15, 2025

Learn to Evaluate (IQV) using the Charts - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 13, 2025

Park Avenue Securities LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

IQVIA Completes $2 Billion Senior Notes Offering - Global Legal Chronicle

Jun 12, 2025
pulisher
Jun 12, 2025

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - Benzinga

Jun 12, 2025
pulisher
Jun 11, 2025

IQVIA unveils AI agents for life sciences using NVIDIA technology By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

IQVIA Launches New AI Agents for Life Sciences and Healthcare - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

IQVIA unveils AI agents for life sciences using NVIDIA technology - Investing.com

Jun 11, 2025
pulisher
Jun 10, 2025

IQVIA Holdings Stock: Is IQV Underperforming The Healthcare Sector? - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

IQVIA Stock: Stuck In A Time SpiralValue Play Or Bull Trap? - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

IQVIA Holdings Inc (IQV) Trading 3.9% Higher on Jun 10 - GuruFocus

Jun 10, 2025
pulisher
Jun 08, 2025

IQVIA Holdings (IQV) Leads S&P 500 Healthcare Gainers - GuruFocus

Jun 08, 2025
pulisher
Jun 04, 2025

IQVIA Holdings Issues $2 Billion in Senior Notes - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

IQVIA Holdings Inc (IQV) Trading 3.85% Higher on Jun 4 - GuruFocus

Jun 04, 2025
pulisher
Jun 03, 2025

IQVIA to raise $2B via senior notes offering to repay debt - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA announces pricing of senior notes - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Rep. Robert Bresnahan, Jr. Sells Off Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing of Senior Notes - 01net

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Inc. (IQV) Secures $2 Billion in Senior Notes Offering - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Holdings Announces $2 Billion Senior Notes Offering - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing of Senior Notes | IQV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Prices $2 Billion Senior Notes Due 2032 - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing Of Senior Notes - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA prices $2 billion senior notes offering - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA announces offering of senior notes - IQVIA

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Offering of Senior Notes - BioSpace

Jun 02, 2025
pulisher
Jun 02, 2025

Iqvia Plans $2 Billion Notes Offering - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Offering of Senior Notes | IQV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA plans $2 billion senior notes offering by 2032 - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Iqvia Announces Offering Of Senior Notes - marketscreener.com

Jun 02, 2025
pulisher
May 31, 2025

IQVIA Holdings Inc. (NYSE:IQV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

May 31, 2025
pulisher
May 31, 2025

What is Zacks Research’s Forecast for IQVIA Q2 Earnings? - Defense World

May 31, 2025
pulisher
May 27, 2025

IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus

May 27, 2025
pulisher
May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com

May 27, 2025

Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Iqvia Holdings Inc-Aktie (IQV) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
DANHAKL JOHN G
Director
Dec 03 '24
Buy
200.58
1,275
255,740
1,275
Sherbet Eric
See Remarks
Aug 27 '24
Sale
246.33
1,300
320,229
19,536
diagnostics_research MTD
$1,153.93
price up icon 0.74%
$171.86
price up icon 0.51%
diagnostics_research LH
$261.88
price up icon 0.19%
diagnostics_research A
$115.56
price up icon 0.03%
diagnostics_research WAT
$342.63
price up icon 0.96%
Kapitalisierung:     |  Volumen (24h):